2022-11-08T22:30:00-06:00 2021-12-31 ERNST & YOUNG US LLP 2323 VICTORY AVENUE SUITE 2000 DALLAS TX 75219 990 2021-01-01 860098929 Vitalant % MAUREEN MUSSELMAN VITA 4809464201 PO Box 1867 Scottsdale AZ 85252 MAUREEN MUSSELMAN EVP, CFO 4806755506 2022-11-07 true MAUREEN MUSSELMAN 999009999 PATRICK SHIELDS P01508556 2149698000 2 2021 2022-09-23 18:48:47Z DAVID GREEN PO BOX 1867 Scottsdale AZ 85252 889691428 false 6167 X www.vitalant.org X 1943 AZ Blood Banking and Research. See Schedule O for more information. 16 16 5200 475 0 0 5980178 16250573 619928642 660841189 21870734 141361429 3891282 18178235 651670836 836631426 1686446 1689490 0 0 341781493 363055941 0 0 0 287317340 315414075 630785279 680159506 20885557 156471920 564968755 765654359 239959199 202509567 325009556 563144792 X BLOOD BANKING AND RESEARCH. SEE SCHEDULE O FOR MORE INFORMATION. false false 483841370 1689490 580479609 Blood Services Division - Blood Banking - See Schedule O 37231639 54097754 Vitalant Laboratories - See Schedule O 41507379 42529230 Vitalant Research Institute - See Schedule O 562580388 true true false true false false false false false true true false false false true true false true false false true false false false false false false true false true false false false false false false false false true false false false false true true true false false true 593 0 true 5200 true false true CJ false false false true true false false false false true false X 16 16 false false false false false false false true true false true true true true true true true true true true true true AL CA FL GA IL KS MI MS NJ NM OH PA RI SC TN WV X MAUREEN MUSSELMAN 4806755506 6210 E OAK ST Scottsdale AZ 85257 DAVID GREEN PRESIDENT/CEO 55.0 1.0 X 1074156 0 51589 ROBERT VAN TUYLE PRESIDENT, BLOOD SERVICES 55.0 0.0 X 638317 0 69763 BHAVI SHAH EVP/CLO, GENERAL COUNSEL 40.0 15.0 X 587550 0 65200 MICHAEL BUSCH MD SVP/RESEARCH & SCIENTIFIC PROG 45.0 0.0 X 599528 0 52802 RALPH VASSALLO EVP/CHIEF MEDICAL & SCIENTIFIC 55.0 0.0 X 599966 0 42693 ANTHONY BOBOS EVP/CHIEF INFORMATION OFFICER 55.0 0.0 X 511517 0 68655 MARY BETH BASSETT EVP/CHIEF QUALITY OFFICER 55.0 0.0 X 516193 0 47498 KEVIN LAND VP, CLINICAL SERVICES 45.0 0.0 X 487030 0 62677 HANY KAMEL MD VP, CORPORATE MEDICAL DIRECTOR 45.0 0.0 X 491593 0 53065 PETER MICHAELSON EVP/CHIEF PEOPLE OFFICER 55.0 0.0 X 449400 0 60046 CHARLES WILCOX III Division VP, Blood Ctr 45.0 0.0 X 455652 0 41964 DIRK JOHNSON EVP/BLOOD SERVICES OPERATIONS 55.0 0.0 X 435221 0 55738 CLIFFORD NUMARK SVP, CHIEF STRAT MKT DONOR SVC 45.0 0.0 X 438944 0 26898 BRIAN CUSTER VP, RESEARCH & SCTFC PROG 45.0 0.0 X 419402 0 40775 MAUREEN MUSSELMAN EVP/CFO 40.0 15.0 X 375677 0 39712 JAMES T SCHRAITH TRUSTEE/VICE CHAIR 3.0 2.0 X X 42875 0 0 ROBERT S COLE Trustee 2.0 0.0 X 33125 0 0 PATRICIA ABREGO-SANTUCCI Trustee 2.0 0.0 X 30625 0 0 BILL GATES TRUSTEE/SECRETARY/TREASURER 3.0 0.0 X X 26875 0 0 WILLIAM A DITTMAN MD Trustee 2.0 0.0 X 25000 0 0 PAUL E STANDER MD TRUSTEE 2.0 0.0 X 25000 0 0 KATHLEEN S PUSHOR TRUSTEE/CHAIR 3.0 0.0 X X 24250 0 0 JOHN S LEWIS Trustee 2.0 1.0 X 24125 0 0 RON W WAECKERLIN MD Trustee 2.0 0.0 X 23000 0 0 SUNNY P CHICO Trustee 2.0 1.0 X 22500 0 0 HEATHER J ALLEN MD Trustee 2.0 1.0 X 21625 0 0 CLIFFORD LOWELL MD PHD Trustee 2.0 0.0 X 20500 0 0 LINDA J BLESSING PHD Trustee 2.0 0.0 X 20500 0 0 Jonathan Waters MD TRUSTEE 3.0 0.0 X 20500 0 0 JAMES PETERSON Trustee 2.0 1.0 X 17500 0 0 RAYMOND PROSPERO JD TRUSTEE 2.0 1.0 X 17500 0 0 PIERRE NOEL MD Trustee (THRU 04/21) 2.0 0.0 X 3125 0 0 8357521 0 779075 502 false true false CREATIVE TESTING SOLUTIONS 2424 W ERIE DRIVE TEMPE AZ 85282 LABORATORY TESTING 55274680 JONES LANG LASALLE AMERICAS INC 200 E RANDOLPH ST STE 4300 CHICAGO IL 60601 FACILITIES MGMT SVCS 11884982 DOME CONSTRUCTION CORPORATION 393 EAST GRAND AVEMIE SOUTH SAN FRANCISCO CA 94080 CONSTRUCTION SVCS 9954129 UPS PO BOX 894820 LOS ANGELES CA 90189 DELIVERY SERVICES 4363141 FORWARD PMX ONE WORLD TRADE CENTER 63RD FLOOR NEW YORK NY 10007 PRINT MGMT SERVICES 3896196 185 2155683 12588444 1506446 738047 16250573 BLOOD & COMPONENT SRV FEE 541900 508716123 508716123 LABORATORY SERVICES 621500 76240412 76240412 RESEARCH CONTRACTS 541700 40240670 40240670 PLASMA FOR FRACTIONATION 541900 35245989 35245989 PHARMACEUTICAL PRODUCTS 446110 397995 397995 660841189 3808492 3808492 0 25686 25686 1887145 1887145 0 1887145 1887145 188560860 2052079 49055821 4004181 139505039 -1952102 137552937 137552937 0 0 0 0 0 0 0 0 0 MISCELLANEOUS INCOME 900099 16138450 16138450 NON-OPERATING MISCELLANEOUS INCOME 900099 126954 126954 16265404 836631426 677106593 143274260 1689490 1689490 0 0 0 6739846 6739846 0 279641962 225737492 53904470 17734931 10270486 7464445 38031457 34411716 3619741 20907745 16673228 4234517 0 689449 689449 656885 656885 24222 24222 0 200545 200545 8339854 3613305 4726549 4119433 787901 3331532 43176530 33866003 9310527 17967609 10376716 7590893 0 38508633 33306152 5202481 11596193 11347962 248231 0 0 238210 238210 0 14418967 9660629 4758338 4826631 4330550 496081 OPERATING & TESTING SUPPLIES 151070429 150107000 963429 PHARM/BLOOD PROD PURCHASE 9138962 9138962 RESEARCH COSTS 3501582 3501582 DONOR RECOGNITION & PROMO 1794326 1247329 546997 5145615 2513885 2631730 680159506 562580388 117579118 0 43072884 84392677 605542 291827 0 0 123799511 129136767 0 0 0 0 0 416537 22829953 18162854 8720031 9896251 390033488 224378165 150401442 165655323 117103707 324132166 69536432 500000 28899253 31770164 0 0 0 1299793 564968755 765654359 180546026 91164788 0 20715747 1063686 4051697 0 0 0 0 0 0 4865338 17246998 0 0 53484149 69330337 239959199 202509567 X 324719045 562870158 290511 274634 325009556 563144792 564968755 765654359 X 156471920 20654592 61008724 X false true X true true true X 6856523 4934147 4705344 5980178 16250573 38726765 478677327 511696316 488055066 622696937 677106593 2778232239 0 0 0 485533850 516630463 492760410 628677115 693357166 2816959004 0 0 0 2816959004 3201381 4707735 21158309 18228814 5721323 53017562 0 3201381 4707735 21158309 18228814 5721323 53017562 0 0 488735231 521338198 513918719 646905929 699078489 2869976566 0.98153 0.98072 0.01847 0.01929 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED false false false false false false true 24222 false false 24222 false SCHEDULE C, PART II-B, LINE 1G A CONSULTANT IS COMPENSATED TO ADVOCATE WITH MEMBERS OF CONGRESS AND THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (HHS) FOR CARES ACT FUNDING TO SUPPORT THE STABILITY OF THE INDEPENDENT BLOOD SUPPLY CHAIN THROUGH DEDICATED FUNDS FOR AMERICA'S BLOOD CENTERS (ABC). THE CONSULTANT ALSO ACTS AS A LIAISON AT THE FEDERAL LEVEL RELATING TO GUIDANCE ISSUED BY HHS FOR THE CARES ACT PROVIDER RELIEF FUND. 101351 283 101634 101365 -14 101351 28252227 5158659 33309521 101365 29958599 101426 -1807798 28252227 27130153 4135779 1307333 29958599 0.00000 1.00000 0.00000 false false 20029143 20029143 130684005 71963948 58720057 36202776 17573803 18628973 143660484 81462957 62197527 59457080 53377457 6079623 165655323 0 PENSION EXPENSE - NOT FUNDED 52734211 LONG TERM RENT STEP UP 5358533 DEFERRED PENSION - TEAMSTERS 5322074 LT TENANT IMPROVEMENT ALLOWANCE 4733363 CURRENT TENANT IMPROVEMENT ALLOW 643520 OTHER 538636 69330337 X SCHEDULE D, PART V, LINE 4 IRWIN MEMORIAL BLOOD CENTER, WHICH WAS MERGED INTO VITALANT, RECEIVED AN ENDOWMENT TO PROVIDE INFORMATION TO BLOOD-TRANSFUSED PATIENTS AND THEIR FAMILIES ON THE MEANS BY WHICH BLOOD UNITS ARE OBTAINED AND THE ESSENTIAL ROLE AND SACRIFICES OF BLOOD DONORS AND TO DEMONSTRATE APPRECIATION OF THE SACRIFICES OF BLOOD DONORS. SCHEDULE D, PART X, LINE 2 AT DECEMBER 31, 2021, THE COMPANY EVALUATED WHETHER IT HAD UNCERTAIN TAX POSITIONS THAT SHOULD BE RECOGNIZED OR DERECOGNIZED BASED ON A "MORE-LIKELY-THAN-NOT" THRESHOLD FOR TAX POSITIONS TAKEN OR EXPECTED TO BE TAKEN IN A TAX RETURN, INCLUDING THOSE TAX POSITIONS THAT WOULD NOT BE SUSTAINED UPON EXAMINATION IN ACCORDANCE WITH GUIDANCE RELATED TO ASC 740, ACCOUNTING FOR UNCERTAINTY IN INCOME TAXES. THE TAX YEARS FOR THE COMPANY THAT ARE SUBJECT TO AUDIT BY THE IRS AND STATE DEPARTMENTS OF REVENUE ARE GENERALLY THE TAX YEARS ENDED DECEMBER 31, 2018, THROUGH THE CURRENT TAX YEAR, EXCEPT IN CERTAIN STATES WHERE THE OPEN TAX YEARS GENERALLY BEGIN WITH THE TAX YEAR ENDED DECEMBER 31, 2017. AS OF DECEMBER 31, 2021, THE COMPANY HAS NOT IDENTIFIED ANY SIGNIFICANT UNCERTAIN TAX POSITIONS THAT WOULD REQUIRE THE RECORDING OF A TAX LIABILITY. THE COMPANY DOES NOT ANTICIPATE A CHANGE IN UNCERTAIN TAX POSITIONS FOR THE 12 MONTHS FOLLOWING THE YEAR ENDED DECEMBER 31, 2021. AS OF DECEMBER 31, 2021, THE COMPANY HAD NO INTEREST OR PENALTIES WHICH QUALIFIED FOR EITHER RECOGNITION OR DISCLOSURE IN THE FINANCIAL STATEMENTS. Central America and the Caribbean 0 0 Program Services Captive Insurance 6817496 0 0 0 0 6817496 6817496 true false true false false false Schedule F, Part I, Line 3, Column (F) THE ORGANIZATION USED THE ACCRUAL METHOD OF ACCOUNTING TO DETERMINE THE AMOUNT IN COLUMN (F). true FLIGHTS FOR LIFE PO BOX 26485 PHOENIX AZ 85068 742453899 501(c)(3) 25000 Donations PHOENIX CHILDREN'S HOSPITAL FOUNDATION 2929 E Camelback Ste 122 phoenix AZ 85016 742421549 501(C)(3) 10000 DONATION-BEACH DAY BENEFIT UNIVERSITY OF PITTSBURGH-DEPT OF MEDICINE 1218 SCAIFE HALL PITTSBURGH PA 15261 250965591 501(C)(3) 1500000 ESTABLISH A HEMOSTASIS CLINIC UNM FOUNDATION 700 LOMAS NE STE 108 ALBUQUERQUE NM 87131 856000642 501(C)(3) 39063 FELLOWSHIP SUPPORT NATIONAL BLOOD FDN RESEARCH & EDUC TRUST FD 4550 MONTGOMERY AVE SUITE 700 NOR BETYHESDA MD 20814 522059102 501(C)(3) 75000 NFB/CORD SUPPORT 5 SCHEDULE I, PART I, LINE 2 SPONSORSHIP AND DONATIONS TO OTHER TAX-EXEMPT ENTITIES ARE MADE IN SUPPORT OF THEIR MISSIONS AND ARE MONITORED VIA THE GOVERNANCE PRACTICES OF THOSE ENTITIES. X X X X false true false false false false false true false DAVID GREEN PRESIDENT/CEO 767086 0 292132 0 14938 0 26000 0 25589 0 1125745 0 0 0 ROBERT VAN TUYLE PRESIDENT, BLOOD SERVICES 464788 0 160682 0 12847 0 26000 0 43763 0 708080 0 0 0 RALPH VASSALLO EVP/CHIEF MEDICAL & SCIENTIFIC 437481 0 149813 0 12672 0 26000 0 16693 0 642659 0 0 0 MICHAEL BUSCH MD SVP/RESEARCH & SCIENTIFIC PROG 432614 0 151424 0 15490 0 26000 0 26802 0 652330 0 0 0 ANTHONY BOBOS EVP/CHIEF INFORMATION OFFICER 369478 0 129647 0 12392 0 26000 0 42655 0 580172 0 0 0 BHAVI SHAH EVP/CLO, GENERAL COUNSEL 405162 0 171040 0 11348 0 19500 0 45700 0 652750 0 0 0 MARY BETH BASSETT EVP/CHIEF QUALITY OFFICER 371617 0 128965 0 15611 0 25830 0 21668 0 563691 0 0 0 HANY KAMEL MD VP, CORPORATE MEDICAL DIRECTOR 352740 0 123789 0 15064 0 24727 0 28338 0 544658 0 0 0 CHARLES WILCOX III Division VP, Blood Ctr 354436 0 87075 0 14141 0 22751 0 19213 0 497616 0 0 0 KEVIN LAND VP, CLINICAL SERVICES 359576 0 126571 0 883 0 24792 0 37885 0 549707 0 0 0 PETER MICHAELSON EVP/CHIEF PEOPLE OFFICER 325602 0 112247 0 11551 0 22892 0 37154 0 509446 0 0 0 DIRK JOHNSON EVP/BLOOD SERVICES OPERATIONS 312139 0 111281 0 11801 0 22330 0 33408 0 490959 0 0 0 CLIFFORD NUMARK SVP, CHIEF STRAT MKT DONOR SVC 354732 0 83788 0 424 0 14500 0 12398 0 465842 0 0 0 BRIAN CUSTER VP, RESEARCH & SCTFC PROG 311494 0 107542 0 366 0 14500 0 26275 0 460177 0 0 0 MAUREEN MUSSELMAN EVP/CFO 363447 0 100 0 12130 0 18935 0 20777 0 415389 0 0 0 SCHEDULE J, PART I, LINE 4B CERTAIN EMPLOYEES PARTICIPATE IN A SUPPLEMENTAL EXECUTIVE RETIREMENT PLAN. NO PAYMENTS WERE MADE IN 2021. THIS PLAN WAS FROZEN AS OF DECEMBER 31, 2011. SCHEDULE J, PART I, LINE 7 VITALANT HAS AN INCENTIVE PLAN FOR MANAGEMENT AND EXECUTIVES. AWARDS UNDER THE PROGRAM ARE AT THE DISCRETION OF THE BOARD OF TRUSTEES. THE PLAN MEASURES PERFORMANCE AGAINST MULTIPLE METRICS WHICH CARRY VARIOUS WEIGHTINGS, THE MOST HEAVILY WEIGHTED BEING QUALITY, SAFETY AND CUSTOMER SERVICE. TO ASSURE FINANCIAL STABILITY OF THE COMPANY, ONE OF THE METRICS IS ALSO A MEASUREMENT OF NET MARGIN, FINANCIAL PERFORMANCE AS A PERCENT OF REVENUES. X RECOGNITION 171 730218 FMV X REFRESHMENTS 19 7131 FMV X OTHER 3 698 FMV false true false SCHEDULE M, PART I, COLUMN (B) THE ORGANIZATION IS REPORTING THE NUMBER OF CONTRIBUTIONS IN COLUMN (B). FORM 990, PART I, LINE 1 AND PART III, LINE 1 VITALANT EXISTS TO MAKE A DIFFERENCE IN PEOPLE'S LIVES BY BRINGING TOGETHER THE BEST PEOPLE, INSPIRING INDIVIDUALS TO DONATE BLOOD, PRODUCING A SAFE AND AMPLE BLOOD SUPPLY, ADVANCING CUTTING-EDGE RESEARCH AND EMBRACING CONTINUOUS QUALITY IMPROVEMENT. Vitalant, one of the nation's oldest and largest nonprofit community blood service providers, supplies comprehensive transfusion medicine services to nearly 900 hospitals and health care partners for patients in need across 40 states. FORM 990, PART III, LINES 4A-D 4A) BLOOD SERVICES DIVISION - BLOOD BANKING THE PRIMARY PURPOSE OF THE BLOOD SERVICES DIVISION (BSD) IS TO PROVIDE A SAFE AND STABLE SUPPLY OF BLOOD AND BLOOD COMPONENTS TO HOSPITALS AND MEDICAL FACILITIES. THE STRENGTH OF BSD IS THAT IT OPERATES AS LOCAL BLOOD CENTERS THAT ARE PART OF THE COMMUNITY AND YET HAS ACCESS TO A LARGE NETWORKED ORGANIZATION WITH ALL THE ADVANTAGES AND EFFICIENCIES THAT ARE REALIZED THROUGH STANDARDIZATION AND ECONOMIES OF SCALE. BSD COLLECTS BLOOD FROM VOLUNTEER DONORS, PERFORMS SCREENING AND TESTING ON THE DONATED BLOOD, AND PROCESSES THE WHOLE BLOOD INTO BLOOD COMPONENTS SUCH AS RED CELL PLATELETS AND PLASMA. BLOOD AND BLOOD COMPONENTS ARE THEN STORED AND DISTRIBUTED TO HOSPITALS AND OTHER HEALTH CARE PROVIDERS. 4B) VITALANT LABORATORIES (VL) VITALANT LABORATORIES' STAFF OF HIGHLY TRAINED AND EXPERIENCED PERSONNEL PROVIDE SUPPORT AND EXPERTISE TO HOSPITALS, TRANSFUSION AND TRANSPLANT CENTERS AND OTHER HEALTHCARE FACILITIES FOR THEIR TRANSFUSION MEDICINE NEEDS. VL OPERATES THREE LABORATORIES FOR (IRL) IMMUNOHEMATOLOGY REFERENCE LAB, (HLA) HISTOCOMPATIBILITY LABORATORY AND (CTL) CELLULAR THERAPY LABORATORY IN PHOENIX, WITH ADDITIONAL IRL'S IN SAN FRANCISCO, DENVER, CHICAGO AND PITTSBURGH. TOGETHER THEY SOLVE SOME OF THE MOST COMPLEX IMMUNOHEMATOLOGIC COMPATIBILITY CASES AND ENSURE LIFE-SAVING BLOOD AND CELLULAR THERAPY SERVICES TO HOSPITALS ALL ACROSS THE UNITED STATES. FOR HEALTHCARE FACILITIES IN CENTRAL ARIZONA, VL ALSO SERVES AS A BLOOD BANK, PROVIDING COMPLETE TRANSFUSION SERVICES INCLUDING PATIENT COMPATIBILITY TESTING AND DELIVERY. 4C) VITALANT RESEARCH INSTITUTE (VRI) THE VITALANT RESEARCH INSTITUTE CARRIES OUT STUDIES FUNDED BY EXTRAMURAL GRANTS (NIH AND OTHER AGENCIES) AND RECEIVES INTRAMURAL FUNDING FROM VITALANT BETWEEN $4.5M AND $5.0M EACH YEAR. VRI HAS HISTORICALLY BEEN NOTED FOR CONTRIBUTIONS TO INFECTIOUS DISEASE TESTING / MONITORING, EPIDEMIOLOGY / PUBLIC POLICY, AND SELECTED NON-INFECTIOUS RISKS OF TRANSFUSION. RECENT RESEARCH EFFORTS INCLUDE CHARACTERIZATION OF METABOLIC AND GENETIC FACTORS THAT INFLUENCE RED BLOOD CELL STABILITY, AND SINCE THE PANDEMIC, A HOST OF CRITICALLY IMPORTANT STUDIES TO UNDERSTAND SARS-COV-2 EPIDEMIOLOGY, THE SAFETY OF THE BLOOD SUPPLY, THE TIME COURSE OF ITS ANTIBODY RESPONSE/IMMUNITY AND THE EFFICACY OF COVID CONVALESCENT PLASMA. A PUBLIC SERVICE, VRI'S RESEARCH EXTENDS FAR BEYOND ORGANIZATIONAL DEVELOPMENT EFFORTS, BENEFITING PATIENTS ALL OVER THE US (AND THE WORLD) AS WELL AS COMPETING US BLOOD CENTERS, IMPROVING BLOOD PRODUCT QUALITY, RECIPIENT SAFETY, AND THE DONOR EXPERIENCE. VRI SUPPORTS TRAINING PROGRAMS FOR SPECIALISTS IN TRANSFUSION MEDICINE AND THE DEVELOPMENT OF RESEARCH SCIENTISTS IN A HOST OF TRANSFUSION MEDICINE SUBSPECIALTIES. VRI INVESTIGATORS PUBLISHED 100 PEER-REVIEWED ORIGINAL RESEARCH PAPERS IN 2021 ALONG WITH MANY MORE REVIEWS, EDITORIALS, BOOK CHAPTERS AND SCIENTIFIC MEETING ABSTRACTS. TOGETHER, VRI'S 12 INVESTIGATORS, 2 CLINICAL INVESTIGATORS, 15 AFFILIATED INVESTIGATORS, 7 CORE LEADERS, 11 ADMINISTRATIVE STAFF AND ~70 SCIENTISTS, TECHNOLOGISTS AND POST-DOCS HAVE CONTRIBUTED TO MAJOR DISCOVERIES IN TRANSFUSION SAFETY AND EFFICACY. FORM 990, PART VI, LINE 1A The Executive Committee has the powers of the Board of Trustees between Board meetings, unless prohibited by law or the Articles of Incorporation. The Executive Committee is composed of 6 or more Trustees, including the Chair, Vice Chair, Secretary-Treasurer, and three or more Trustees selected by the Board of Trustees. FORM 990, PART VI, LINE 11B THE FORM 990 IS REVIEWED BY MANAGEMENT, INCLUDING CONFIRMATION OF COMPENSATION DISCLOSURES AGAINST W-2 AND 1099 REPORTING. A COPY OF THE DRAFT FORM 990 AND ALL SCHEDULES IS SUPPLIED TO ALL BOARD MEMBERS PRIOR TO THE MEETING held to approve the filing of the tax returns. THE W-2S AND 1099S ARE AVAILABLE FOR BOARD REVIEW UPON REQUEST. THE PAID PREPARER, ERNST & YOUNG, AND MEMBERS OF MANAGEMENT REVIEW THE FORM 990 WITH THE BOARD'S AUDIT COMMITTEE AND ARE AVAILABLE FOR ANSWERING QUESTIONS. ANY COMMENTS FROM THE BOARD ARE CONSIDERED PRIOR TO FILING WITH THE IRS. FORM 990, PART VI, LINE 12C EACH YEAR, THE Board of Trustees, Officers and Key Employees ARE REQUIRED TO SIGN AND RETURN A CONFLICT OF INTEREST FORM TO COMPANY COUNSEL. ANY CONFLICTS DISCLOSED ARE DISCUSSED IN EXECUTIVE SESSION WITH THE BOARD'S AUDIT COMMITTEE AND RESOLVED. IN ADDITION, IN PREPARATION FOR THE FORM 990 FILING, all individuals considered to be 'Disqualified Persons' are required to respond to a comprehensive CONFLICT OF INTEREST AND FAMILY RELATIONSHIP QUESTIONNAIRE. ANY CONFLICTS DISCLOSED ARE DISCUSSED WITH THE BOARD'S AUDIT COMMITTEE AND DISCLOSED APPROPRIATELY ON THE FORM 990. FORM 990, PART VI, LINES 15A AND 15B THE BOARD OF TRUSTEES HAS A COMPENSATION AND HUMAN RESOURCE COMMITTEE WHOSE PURPOSE, AMONG OTHER THINGS, IS TO HIRE AN INDEPENDENT CONSULTING FIRM ONCE EVERY 2-3 YEARS TO PROVIDE DATA ON COMPETITIVENESS OF SALARIES AND BENEFITS FOR THE CEO, OFFICERS AND OTHER KEY EMPLOYEES OF THE CORPORATION. THIS PROCESS WAS COMPLETED IN 2020. THE MEMBERS OF THE HUMAN RESOURCE AND COMPENSATION COMMITTEE OF THE BOARD ARE ALL INDEPENDENT TRUSTEES AND INCLUDE NO MEMBERS OF MANAGEMENT. THE RECOMMENDATIONS OF THE COMMITTEE ARE REVIEWED BY THE ENTIRE BOARD PRIOR TO APPROVAL. COMPENSATION FOR THESE INDIVIDUALS IS SET AND APPROVED BY THE BOARD EACH YEAR. THE RESULTS OF THESE DISCUSSIONS, REVIEWS AND APPROVALS ARE DOCUMENTED IN THE EXECUTIVE SESSION MINUTES OF THE BOARD MEETINGS. FORM 990, PART VI, LINE 19 UPON WRITTEN REQUEST TO THE CHIEF FINANCIAL OFFICER, A COPY OF THE FORM 990 WILL BE MAILED TO THE REQUESTER. THE FORM 990 FOR CURRENT AND PAST YEARS IS ALSO POSTED ON GUIDESTAR FOR ORGANIZATIONS TO ACCESS. THE GOVERNING DOCUMENTS AND CONFLICT OF INTEREST POLICY ARE NOT MADE AVAILABLE TO THE PUBLIC. THE ORGANIZATION'S COMBINED FINANCIAL STATEMENTS ARE MADE AVAILABLE UPON REQUEST. FORM 990, PART XI, LINE 9 BIOCARE RETAINED EARNINGS ADJUSTMENT $37,886,131 PENSION GAIN $23,122,593 ------------ TOTAL CHANGES IN NET ASSETS $61,008,724 BLOOD SCIENCE FOUNDATION 875 GREENTREE RD PKWY CTR 5 PITTSBURGH PA 15220 251562715 FUNDRAISING PA 501(c)(3) 12D-III-O NA false Blood Center Foundation Inland Northwest 210 W Cataldo Avenue SPOKANE WA 99201 464347438 FUNDRAISING WA 501(c)(3) 12D-III-O na false BLOOD BANK SAN BERNARDINORIVERSIDE FDN PO BOX 1429 SAN BERNARDINO CA 92402 208911074 FUNDRAISING CA 501(C)(3) 12A-I BBSBRC true CANYON STATE INSURANCE COMPANY PO BOX 1085 113 S CHURCH ST GRAND CAYMAN CJ KY1-1102 981084327 CAPTIVE INSURANCE CJ VITALANT C Corp 3284133 36690440 1.00000 true BIOCARE INC 6210 E OAK STREET SCOTTSDALE AZ 85257 813906720 PHARMA AZ VITALANT C Corp 5120922 0 0.00000 true false true false false false true true false true false true true false true true true true true LIFESTREAM g 5141003 ACCRUAL LIFESTREAM h 2416025 ACCRUAL CANYON STATE INSURANCE COMPANY r 4987246 ACCRUAL LifeStream q 440798 ACCRUAL LifeStream l 1352156 ACCRUAL Hemophilia Center of Western Pennsylvania l 606457 ACCRUAL SCHEDULE R, PART II THERE ARE VARIOUS RELATED TAX-EXEMPT BLOOD BANKING ORGANIZATIONS THAT ARE INCLUDED IN A GROUP EXEMPTION, AND THEREFORE, IN ACCORDANCE WITH THE FORM 990 INSTRUCTIONS ARE NOT REPORTED ON SCHEDULE R, PART II.